Overview

Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN)

Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
Phase II clinical trial
Phase:
Phase 2
Details
Lead Sponsor:
Legacy Healthcare SA
Treatments:
Pharmaceutical Solutions